Experimental Ebola trial begins in Congo as death toll tops 500
ONP Summary
An Ebola outbreak spanning Congo and neighboring Uganda has claimed over 500 lives among more than 1,500 confirmed cases. Researchers have initiated a clinical trial testing an experimental monoclonal antibody and antiviral therapy, while frontline healthcare workers threaten work stoppages over unpaid wages and hazardous conditions.
Progressive: System failure — Worker strikes and vaccine shortages reveal inadequate healthcare infrastructure unable to properly support frontline staff during outbreak response.
Moderate: Complex response — Controlling Ebola demands both scientific innovation through drug trials and social intervention addressing community fear and stigma.
Conservative: Clinical opportunity — Experimental treatments offer a medical pathway to containing the outbreak despite ongoing casualties.
The World Health Organization-sponsored trial will test the monoclonal antibody cocktail MBP134 and the antiviral remdesivir alongside optimized supportive care. ...
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요